Strong Market Position Delfina demonstrates rapid growth with revenue estimated between $50M and $100M and successfully attracting substantial Series A funding of $17M from prominent investors like US Venture Partners, Mayo Clinic, and Tokio Marine Future Fund, highlighting strong investor confidence and scalability potential.

Recognition and Awards The company has received notable industry recognition, including the Best Maternal Health Platform award from MedTech Breakthrough, establishing its credibility and appeal as a leading innovator in maternal health technology.

Strategic Partnerships Recent collaborations with UnitedHealthcare indicate emerging opportunities to expand into large-scale healthcare provider networks, enabling strategic integration of Delfina’s AI-powered prenatal care solutions.

Innovative Technology Delfina leverages advanced tech like AI, data analytics, and a modern tech stack, positioning it well to meet increasing demand for personalized, data-driven pregnancy management solutions in healthcare institutions.

Market Growth Potential With a dedicated team of 201-500 employees and a focus on addressing the maternal health crisis, Delfina is well-positioned to capitalize on market trends toward improved maternal outcomes and digital health innovation, offering multiple touchpoints for expanding sales outreach.